OSCAR 15

K172180 · Genoray Co., Ltd. · OWB · Feb 9, 2018 · Radiology

Device Facts

• Record ID: K172180
• Device Name: OSCAR 15
• Applicant: Genoray Co., Ltd.
• Product Code: OWB · Radiology
• Decision Date: Feb 9, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 892.1650
• Device Class: Class 2

Intended Use

OSCAR 15 is a mobile fluoroscopy system designed to provide fluoroscopic and spot film images of the patient during diagnostic, surgical and interventional procedures. Examples of clinical application may include cholangiography, endoscopy, urologic, orthopedic, neurologic, vascular, cardiac and critical care. The system may be used for other imaging applications at the physician's discretion.

Device Story

Mobile C-arm fluoroscopy system; captures X-ray radiation patterns; converts to visible images via CMOS flat panel detector; provides real-time fluoroscopic and spot film images. Used in hospitals/clinics by physicians for diagnostic, surgical, and interventional procedures (e.g., orthopedic, vascular, cardiac). Physician views images on integrated monitor to guide procedures; eliminates need for film development. Benefits include real-time visualization of anatomical structures, improved image uniformity, lack of geometric distortion, and reduced physical footprint compared to image intensifier systems.

Clinical Evidence

Bench testing only. Performance evaluated against IEC 60601-1 series, IEC 60601-1-2 (EMC), and 21 CFR 1020.30-32 (EPRC). Comparison of technical specifications (DQE, resolution, MTF) provided to demonstrate equivalence to predicate. No clinical study data reported.

Technological Characteristics

Mobile C-arm fluoroscopic X-ray system; 15 kW high-frequency inverter generator; rotating X-ray tube (0.3/0.6 mm focal spots); CMOS flat panel detector (260x256 mm active area, 100 μm pixel pitch, CsI scintillator). Connectivity: Standalone system (no wireless function). Compliance: IEC 60601-1, IEC 60601-1-3, IEC 60601-2-28, IEC 60601-2-43, IEC 60601-2-54, and 21 CFR 1020.30-32.

Indications for Use

Indicated for patients undergoing diagnostic, surgical, and interventional procedures requiring fluoroscopic and spot film imaging, including cholangiography, endoscopy, urologic, orthopedic, neurologic, vascular, cardiac, and critical care applications.

Regulatory Classification

Identification

An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Special Controls

*Classification.* Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

• ZEN-7000 (K140041)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.

February 9, 2018

GENORAY Co., Ltd. % Ms. Kaitlynn Min Business Development GENORAY America Inc. 147 E. Bristol Lane ORANGE CA 92865

Re: K172180

Trade/Device Name: Oscar 15 Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: OWB, JAA Dated: December 28, 2017 Received: January 2, 2018

Dear Ms. Min:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Michael D. O'Hara
For

Robert Ochs, Ph.D Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K172180

Device Name

OSCAR 15

Indications for Use (Describe)

OSCAR 15 is a mobile fluoroscopy system is designed to provide fluoroscopic and spot film images of the patient during diagnostic, surgical and interventional procedures. Examples of clinical application may include cholangiography, endoscopy, urologic, orthopedic, neurologic, vascular, cardiac and critical care.

The system may be used for other imaging applications at the physician's discretion.

| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| <span style="font-size:10pt"><svg height="15" width="15"><path d="M2 2 L13 2 L13 13 L2 13 Z M4 4 L11 4 L11 11 L4 11 Z" fill="black"></path></svg></span> Prescription Use (Part 21 CFR 801 Subpart D) | <span style="font-size:10pt"><svg height="15" width="15"><path d="M2 2 L13 2 L13 13 L2 13 Z" fill="white" stroke="black"></path></svg></span> Over-The-Counter Use (21 CFR 801 Subpart C) |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) Summary

Date of Summary Preparation: July. 04, 2017

| 1. Submitter and US Official Correspondent | |
|--------------------------------------------|--------------------------------------|
| Submitter : | GENORAY Co., Ltd. |
| Address: | 512, 560, Dunchon-daero, Jungwon-gu, |
| | Seongnam-si, Gyeonggi-Do, Korea |
| Telephone No.: | [phone] |
| Fax: | [phone] |

Official Correspondent (U.S): Kaitlynn Min - Business Manager Correspondent: GENORAY America Inc. Address: 147 E. Bristol Lane, Orange, CA 92865 USA Telephone No.: [phone] [phone] Fax: Email: [e-mail]

- 2. Establishment Registration Number 3005843418
### 3. Device Information

| Trade/Device Name: | OSCAR 15 |
|---------------------------|------------------------------------------------------|
| Regulation Name: | Fluoroscopic X-ray System |
| Classification Name: | Interventional Fluoroscopic X-Ray System |
| Product Code: | OWB / Interventional Fluoroscopic X-Ray System |
| Subsequence product code: | JAA / System, X-Ray, Fluoroscopic, Image-Intensified |
| Device Class: | Class II per regulation 21 CFR 892.1650 |

- Predicate Device (Equivalent Legally Marketed Device) 4.

| Manufacturer: | GENORAY Co., Ltd |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device Name: | ZEN-7000 |
| 510(k) Number: | K140041 (Decision Date - November 28, 2014) |
| Classification: | Interventional Fluoroscopic X-Ray System/OWB<br>Image Intensified Fluoroscopic X-Ray System, Mobile/OXC<br>System, X-Ray, Fluoroscopic, Image-Intensified/JAA<br>Class II per regulation 21 CFR 892.1650 |

{4}------------------------------------------------

### 5. Description of the Device

OSCAR 15 is consist of X-ray Tube, X-ray tube assembly, x-ray controller, detector and accessories. There is no wireless function in this device.

The OSCAR 15, C-Arm Mobile is the device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This device is used for providing fluoroscopic and radiographic images of patient anatomy, especially during the special procedures in a hospital or medical clinics. The fluoroscopic mode of operation is very useful to the attending physician to see the images on real time without the need to develop individual films.

#### 6. Indications for use (intended use)

OSCAR 15 is a mobile fluoroscopy system designed to provide fluoroscopic and spot film images of the patient during diagnostic, surgical and interventional procedures. Examples of clinical application may include cholangiography, endoscopy, urologic, orthopedic, neurologic, vascular, cardiac and critical care. The system may be used for other imaging applications at the physician's discretion.

| Name | Proposed device<br>OSCAR 15 | Predicate device<br>ZEN-7000 |
|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | GENORAY Co., Ltd. | GENORAY Co., Ltd. |
| 510(k) No. | - | K140041 |
| Indications<br>for use | OSCAR 15 is a mobile fluoroscopy<br>system designed to provide<br>fluoroscopic and spot film images of<br>the patient during diagnostic, surgical<br>and interventional procedures.<br>Examples of clinical application may<br>include cholangiography, endoscopy,<br>urologic, orthopedic, neurologic,<br>vascular, cardiac and critical care.<br>The system may be used for other<br>imaging applications at the<br>physician's discretion. | ZEN-7000 is a mobile fluoroscopy<br>system designed to provide<br>fluoroscopic and spot film images of<br>the patient during diagnostic, surgical<br>and interventional procedures.<br>Examples of clinical application may<br>include cholangiography, endoscopy,<br>urologic, orthopedic, neurologic,<br>vascular, cardiac, critical care and<br>emergency room procedures. The<br>system may be used for other<br>imaging applications at the<br>physician's discretion. |
| Name | Proposed device | Predicate device |
| | OSCAR 15 | ZEN-7000 |
| Manufacturer | GENORAY Co., Ltd. | GENORAY Co., Ltd. |
| 510(k) No. | - | K140041 |
| Generator | High Frequency Inverter | High Frequency Inverter |
| Max. output power | 15 kW | 5 kW |
| | | 15 kW (Optional) |
| X-ray Tube | Rotating tube | Rotating tube |
| | Large : 0.6 mm | Large : 0.6 mm |
| | Small : 0.3 mm | Small : 0.3 mm |
| Fluoroscopy | 40-120 kV / 0.2-6.0 mA | 40-120 kV/ 0.2-6.0 mA |
| Pulsed Fluoroscopy | 1 mA to 48 mA | 1 mA to 20 mA(5kW) |
| | | 1 mA to 48 mA(15kW) |
| Radiography | 40-120 kV / 0.4-100 mAs | 40-120 kV / 1-100 mAs |
| Detector | Active image area : 260 x 256 mm<br>Central Resolution 4.6 lp/mm<br>Contrast Ratio (10%) : 30:1<br>Type : CMOS<br>Resolution : 2600 x 2560<br>Pixel sampling resolution : 14 bits<br>Pixel pitch : 100 μm<br>MTF: 56%<br>DQE: 59%<br>Scintillator : CsI | 9" (9"/6"/4.5")<br>● Minimum central resolution<br>(at the monitor):<br>-9" (23cm): 2.2 lp/mm<br>-6" (15cm): 2.8 lp/mm<br>-4.5" (11cm): 3.0 lp/mm<br>● DQE: 65% (typical)<br>12" (12"/9"/6")<br>● Minimum central resolution<br>(at the monitor):<br>-12" (31cm): 1.6 lp/mm<br>-9" (23cm): 2.0 lp/mm<br>-6" (15cm): 2.5 lp/mm<br>● DQE: 65% (typical) |
| Dimensions | SID : 1000 mm<br>Panning Rotation: ±12.5°<br>Orbital Rotation: 155°<br>Vert. Travel: 500 mm<br>Horiz. Travel: 200 mm | SID : 1000 mm<br>Panning Rotation: ±12.5°<br>Orbital Rotation: 135°<br>Vert. Travel: 500mm<br>Horiz. Travel: 200mm |

#### Substantial equivalence chart 7.

{5}------------------------------------------------

The proposed OSCAR 15 is based on the predicate device, ZEN-7000(K140041). The generator is similar to predicate device with output power, 15 kW. Also X-ray tube of OSCAR 15 is same with predicate device.

{6}------------------------------------------------

The difference between OSCAR 15 and predicate device is the options of Image acquisition parts. OSCAR 15 is Flat panel detector and predicate device is Image Intensifier. As mentioned in the comparison table, predicate device DQE is higher than OSCAR 15. However, predicate device DQE is the DQE of the image intensifier itself. In general, when image intensifier is combined with CCD camera the DQE decreases. In conclusion, the DQE of the complete predicate device is 51%. So the DQE of the OSCAR 15 is more effective and safety than predicate device. Also flat panel detector type has excellent image uniformity, no geometric distortion, no veiling glare or vignetting, small and thin physical size as compared to the Image Intensifier type.

The OSCAR 15 is substantially equivalent to the predicate device, ZEN-7000(K140041).

- 8. Safety, EMC and Performance data comparison to Predicate
OSCAR 15 complies with industry standards such as IEC 60601-1 Series and 21 CFR 1020.30, 21 CFR 1020.31 and 21 CFR 1020.32 to minimize electrical, mechanical and radiation hazards.

- Electrical, mechanical, environmental safety and performance testing according to standard IEC 60601-1, IEC 60601-1-3, IEC 60601-2-28, IEC 60601-2-43 and IEC 60601-2-54 were performed.

- EMC testing was conducted in accordance with standard IEC 60601-1-2.
- OSCAR 15 meets the EPRC standards (21 CFR 1020.30, 31, 32).
- FDA guidance "guidance for SSXI devices". "guidance for the Content of Premarket Submissions for Software Contained in Medical devices", and "content of premarket submissions for management of cyber security" was performed for OSCAR 15.

All test results were satisfactory and the result of bench and clinical evaluation indicates that the new device is as safe and effective as the predicate device.

- 9. Conclusion
In reference to the comparison information provided in substantial equivalence chart, and the most of functions and electronic features are similar with predicate device. We believe that the OSCAR 15 is safe and effective as predicate device, and has no new indication for use. Therefore, OSCAR 15 is substantially equivalent to predicate device.